课题基金 / 基金详情

CHOLESTEROL REDUCTION WITH LDL APHERESIS IN HYPERCHOLESTEROLEMIA

CHOLESTEROL REDUCTION WITH LDL APHERESIS IN HYPERCHOLESTEROLEMIA
通过低密度脂蛋白血浆分离术降低高胆固醇血症中的胆固醇
批准号：
5220222
负责人：
D ROGER ILLINGWORTH
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5220222
关键词：
biomedical equipment safety clinical biomedical equipment clinical research familial hyperlipoproteinemia type II human subject human therapy evaluation hypercholesterolemia low density lipoprotein physical separation plasmapheresis

项目摘要

项目成果

D ROGER ILLINGWORTH的其他基金

相关文献

中文摘要
翻译
涉及物理去除血浆的各种技术或选择性 去除低密度脂蛋白(LDL)已被用于治疗 严重的高胆固醇血症。本项目旨在评估 LA15低密度脂蛋白吸附柱的疗效和安全性 严重杂合子家族性疾病的治疗 高胆固醇血症。
英文摘要
Various techniques involving physical removal of plasma or selective removal of low density lipoproteins (LDL) have been used in the therapy of severe hypercholesterolemia. The present project aims to assess the efficacy and safety of the liposorber LA15, LDL adsorption column for the treatment of patients with severe heterozygous familial hypercholesterolemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of simvastatin on postprandial hyperlipidemia
REGULAR AND SUSTAINED RELEASE SIMVISTATIN IN HYPERCHOLESTEROLEMIA
SIMVASTATIN ON STEROID HORMONE PRODUCTION IN MEN WITH HYPERCHOLESTEROLEMIA
THE EFFECTS OF HIGH DOSE SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA